|
MechanismH2 receptor antagonists |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismH2 receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ikeda Mohando Ltd.
0 Patents (Medical) associated with Ikeda Mohando Ltd.
100 Deals associated with Ikeda Mohando Ltd.
100 Translational Medicine associated with Ikeda Mohando Ltd.